Section Arrow
Quote
MLTX.NASDAQ
- MoonLake Immunotherapeutics
Quotes are at least 15-min delayed:2026/01/10 11:37 EST
Regular Hours
Last
 18.49
+4.15 (+28.94%)
Day High 
18.65 
Prev. Close
14.34 
1-M High
16.39 
Volume 
14.67M 
Bid
19.3
Ask
19.4
Day Low
14.92 
Open
15.17 
1-M Low
11.06 
Market Cap 
1.02B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 12.77 
20-SMA 13.43 
50-SMA 12.78 
52-W High 62.75 
52-W Low 5.95 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.33/-2.97
Enterprise Value
1.02B
Balance Sheet
Book Value Per Share
4.08
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4944+0.11+28.62%-- 
ASBPAspire Biopharma Holdings Inc.0.104+0.0007+0.68%-- 
RVMDRevolution Medicines118.64+11.25+10.48%-- 
ARDXArdelyx7.74+0.74+10.57%-- 
SLSSELLAS Life Sciences Group3.46-0.4-10.36%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.